Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-18

Clinical Trial Update: The Effect of Eszopiclone on the Arousal Threshold in Sleep Apnea Syndrome [EARLY_Phase 1]

View source ↗

Summary

Early Phase 1 trial evaluating eszopiclone's effect on arousal threshold in obstructive sleep apnea has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lunesta (eszopiclone)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Obstructive Sleep Apnea | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2017-04-18